These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15356823)

  • 1. Rifampin and pyrazinamide for latent tuberculosis infection: clinical trials and general practice.
    Saukkonen J
    Clin Infect Dis; 2004 Aug; 39(4):566-8. PubMed ID: 15356823
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of latent tuberculosis infection: back to the beginning.
    Blumberg HM
    Clin Infect Dis; 2004 Dec; 39(12):1772-5. PubMed ID: 15578398
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of intermittent rifampin and pyrazinamide therapy for latent tuberculosis infection in a targeted tuberculin testing program.
    Priest DH; Vossel LF; Sherfy EA; Hoy DP; Haley CA
    Clin Infect Dis; 2004 Dec; 39(12):1764-71. PubMed ID: 15578397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
    Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of latent tuberculosis infection in immigrants.
    Sterling T; Munsiff SS; Frieden TR
    N Engl J Med; 2003 Mar; 348(13):1289-92; author reply 1289-92. PubMed ID: 12661573
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infection.
    Ijaz K; McElroy PD; Jereb J; Navin TR; Castro KG
    Clin Infect Dis; 2007 Feb; 44(3):464-5; author reply 465. PubMed ID: 17205462
    [No Abstract]   [Full Text] [Related]  

  • 7. The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy.
    Grosset J
    Bull Int Union Tuberc; 1978 Mar; 53(1):5-12. PubMed ID: 656653
    [No Abstract]   [Full Text] [Related]  

  • 8. US guidelines for treatment of latent tuberculosis revised.
    McCarthy M
    Lancet; 2001 Sep; 358(9284):816. PubMed ID: 11564495
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on the treatment of tuberculosis.
    Inge LD; Wilson JW
    Am Fam Physician; 2008 Aug; 78(4):457-65. PubMed ID: 18756652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent tuberculous infection.
    Yun JS; Lazarus AA; Gilbert R
    Dis Mon; 2006; 52(11-12):441-5. PubMed ID: 17157617
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
    Byrne ST; Denkin SM; Zhang Y
    J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal latent TB control methods.
    Ridzon R
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):236. PubMed ID: 15786884
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus?
    Tortajada C; Martínez-Lacasa J; Sánchez F; Jiménez-Fuentes A; De Souza ML; García JF; Martínez JA; Caylà JA;
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):276-81. PubMed ID: 15786890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of tuberculosis after apparently adequate chemoprophylaxis.
    Currie GP; Emmanuel FX; Ford D; Devereux G
    J Infect; 2005 Dec; 51(5):e305-8. PubMed ID: 16321645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis.
    Ena J; Valls V
    Clin Infect Dis; 2005 Mar; 40(5):670-6. PubMed ID: 15714411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens.
    Lambert LA; Ijaz K; Navin TR
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):230; author reply 230-1. PubMed ID: 15732748
    [No Abstract]   [Full Text] [Related]  

  • 17. Postoperative Mycobacterium tuberculosis infection after total knee arthroplasty.
    Lee CL; Wei YS; Ho YJ; Lee CH
    Knee; 2009 Jan; 16(1):87-9. PubMed ID: 18974007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
    Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
    Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
    Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
    Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doctors report breakthrough antibiotic treatment for TB.
    AIDS Read; 2007 Nov; 17(11):528, 534. PubMed ID: 18167636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.